569 related articles for article (PubMed ID: 33240271)
21. CD4+ and CD8+ Circulating Memory T Cells Are Crucial in the Protection Induced by Vaccination with
Ontiveros-Padilla L; García-Lozano A; Tepale-Segura A; Rivera-Hernández T; Pastelin-Palacios R; Isibasi A; Arriaga-Pizano LA; Bonifaz LC; López-Macías C
Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33916894
[No Abstract] [Full Text] [Related]
22. Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.
Cheng Y; Gunasegaran B; Singh HD; Dutertre CA; Loh CY; Lim JQ; Crawford JC; Lee HK; Zhang X; Lee B; Becht E; Lim WJ; Yeong J; Chan CY; Chung A; Goh BKP; Chow PKH; Chan JKY; Ginhoux F; Tai D; Chen J; Lim SG; Zhai W; Choo SP; Newell EW
Immunity; 2021 Aug; 54(8):1825-1840.e7. PubMed ID: 34270940
[TBL] [Abstract][Full Text] [Related]
23. Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor.
Bai X; Wang X; Ma G; Song J; Liu X; Wu X; Zhao Y; Liu X; Liu Z; Zhang W; Zhao X; Zheng Z; Jing J; Shi H
Front Immunol; 2021; 12():793831. PubMed ID: 34987517
[TBL] [Abstract][Full Text] [Related]
24. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
[TBL] [Abstract][Full Text] [Related]
25. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
26. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
27.
Cheng Y; Lemke-Miltner CD; Wongpattaraworakul W; Wang Z; Chan CHF; Salem AK; Weiner GJ; Simons AL
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060147
[TBL] [Abstract][Full Text] [Related]
28. Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.
Moreno-Eutimio MA; Tenorio-Calvo A; Pastelin-Palacios R; Perez-Shibayama C; Gil-Cruz C; López-Santiago R; Baeza I; Fernández-Mora M; Bonifaz L; Isibasi A; Calva E; López-Macías C
Immunology; 2013 Aug; 139(4):459-71. PubMed ID: 23432484
[TBL] [Abstract][Full Text] [Related]
29. Targeting Resident Memory T Cells for Cancer Immunotherapy.
Blanc C; Hans S; Tran T; Granier C; Saldman A; Anson M; Oudard S; Tartour E
Front Immunol; 2018; 9():1722. PubMed ID: 30100906
[TBL] [Abstract][Full Text] [Related]
30. Tissue-resident memory T cells in tumor immunity and immunotherapy.
Okła K; Farber DL; Zou W
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33755718
[TBL] [Abstract][Full Text] [Related]
31. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral CD8
Virassamy B; Caramia F; Savas P; Sant S; Wang J; Christo SN; Byrne A; Clarke K; Brown E; Teo ZL; von Scheidt B; Freestone D; Gandolfo LC; Weber K; Teply-Szymanski J; Li R; Luen SJ; Denkert C; Loibl S; Lucas O; Swanton C; Speed TP; Darcy PK; Neeson PJ; Mackay LK; Loi S
Cancer Cell; 2023 Mar; 41(3):585-601.e8. PubMed ID: 36827978
[TBL] [Abstract][Full Text] [Related]
33. Resident memory CD8
Molodtsov AK; Khatwani N; Vella JL; Lewis KA; Zhao Y; Han J; Sullivan DE; Searles TG; Preiss NK; Shabaneh TB; Zhang P; Hawkes AR; Malik BT; Kolling FW; Usherwood EJ; Wong SL; Phillips JD; Shirai K; Angeles CV; Yan S; Curiel TJ; Huang YH; Cheng C; Turk MJ
Immunity; 2021 Sep; 54(9):2117-2132.e7. PubMed ID: 34525340
[TBL] [Abstract][Full Text] [Related]
34. Neem leaf glycoprotein promotes dual generation of central and effector memory CD8(+) T cells against sarcoma antigen vaccine to induce protective anti-tumor immunity.
Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Saha A; Dasgupta S; Barik S; Bose A; Baral R
Mol Immunol; 2016 Mar; 71():42-53. PubMed ID: 26851529
[TBL] [Abstract][Full Text] [Related]
35. IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector.
Colombetti S; Lévy F; Chapatte L
Blood; 2009 Jun; 113(26):6629-37. PubMed ID: 19383968
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral vaccines promote protective tissue-resident memory T cell populations against cancer.
van der Gracht ET; Schoonderwoerd MJ; van Duikeren S; Yilmaz AN; Behr FM; Colston JM; Lee LN; Yagita H; van Gisbergen KP; Hawinkels LJ; Koning F; Klenerman P; Arens R
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33293355
[TBL] [Abstract][Full Text] [Related]
37. Attenuated Oral Typhoid Vaccine Ty21a Elicits Lamina Propria and Intra-Epithelial Lymphocyte Tissue-Resident Effector Memory CD8 T Responses in the Human Terminal Ileum.
Booth JS; Patil SA; Goldberg E; Barnes RS; Greenwald BD; Sztein MB
Front Immunol; 2019; 10():424. PubMed ID: 30923521
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells.
Martinez-Usatorre A; Carmona SJ; Godfroid C; Yacoub Maroun C; Labiano S; Romero P
Front Immunol; 2020; 11():340. PubMed ID: 32174925
[TBL] [Abstract][Full Text] [Related]
39. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
40. Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors.
Chapatte L; Colombetti S; Cerottini JC; Lévy F
Cancer Res; 2006 Jan; 66(2):1155-60. PubMed ID: 16424053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
